Skip to content
Search

Latest Stories

FIP policy statement emphasises pharmacy's vital role in life-course vaccination

The International Pharmaceutical Federation (FIP) has issued a new policy statement which encourages a “life-course” approach to vaccination by pharmacists.

In the statement, published on September 27, FIP backed expansion of vaccine schedules and strategies so that patients of all age groups could be vaccinated throughout their entire lifespan, from infancy to old age.


A life-course approach in public health and healthcare focuses on an individual's health and well-being, including  vaccination, administered throughout their entire lifespan, from infancy to old age.

FIP urged governments and policymakers to eliminate regulatory barriers, enabling pharmacists to prescribe and administer all relevant vaccines throughout the life-course. Additionally, FIP recommended that policymakers develop remuneration models for pharmacies to deliver sustainable life-course vaccination services within the private and public sectors.

“A life-course immunisation approach recognises that health is shaped by a series of events that occur throughout life, including vaccinations known to benefit specific age groups and vulnerable groups,” said Luís Lourenço, FIP professional secretary and co-chair of the FIP policy committee that developed the statement.

“Vaccine-preventable diseases are a significant cause of morbidity, including loss of functional ability, and mortality in older people because a gradual deterioration of the immune system brought on by increased age makes them more susceptible to infections,” Lourenço added.

The federation emphasised the integration of pharmacists into immunisation pathways for older individuals and other special-risk groups, including those with long-term conditions, pregnant individuals, healthcare professionals, underserved populations, and caregivers.

Furthermore, the policy statement underscored the role of pharmacists in bolstering vaccine confidence and mitigating vaccine hesitancy. "Enhancing accessibility, a key driver for boosting vaccination rates across all age groups, is an area where pharmacy can make a significant contribution," Lourenço added.

To enable pharmacists to actively participate in life-course vaccination, the policy statement provides recommendations for various stakeholders including governments, policymakers, FIP member organisations, as well as pharmacy practitioners and educators.

Meanwhile, here in the UK, the pharmacy vision document, jointly published by Nuffield Trust and The King’s Fund, highlighted that achieving the community pharmacy vision hinges on legal adjustments and supplementary funding, beyond recent boosts. However, it identifies enduring obstacles in realising this vision. These stem from outdated infrastructure, equipment, and IT systems, as well as challenges in staff training, regulation, and the seamless integration of pharmacies with other primary care services.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less